As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

Clear Regulatory Path to Clinical Trials for Intranasal PTSD Therapy Targeting Multi-Billion-Dollar MarketSARASOTA, FL, May ...

Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, published on major advances to Enchant, Iambic’s ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

Factors Affecting the Growth of the Artificial Intelligence For Drug Development and Discovery Industry: ...

Valinor Discovery, a company pioneering machine learning-powered simulation of therapeutic performance to derisk drug development, today exited stealth to announce their mission to train the first ...

FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...